Using stem cells to treat various chronic and acute health conditions
Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions
PHASE1; PHASE2 · Thomas Advanced Medical LLC · NCT04684602
This study is testing if stem cell therapy can help people with different long-term and short-term health issues, like autoimmune diseases and heart problems, feel better and improve their quality of life.
Quick facts
| Phase | PHASE1; PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Thomas Advanced Medical LLC (industry) |
| Locations | 1 site (Culver City, California) |
| Trial ID | NCT04684602 on ClinicalTrials.gov |
What this trial studies
This multi-arm, multi-site study evaluates the safety, tolerability, and efficacy of stem cell therapy for a range of acute and chronic conditions, including autoimmune diseases, cardiovascular disorders, and diabetes complications. The study is designed to gather clinical outcomes using various validated instruments that assess both general quality of life and condition-specific metrics. Participants will receive treatments with PrimePro™ or PrimeMSK™ stem cell therapies, with follow-up visits to monitor their progress and response to treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who can provide informed consent and are available for follow-up visits.
Not a fit: Patients with active or recent malignancy, those who are pregnant or breastfeeding, or individuals unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide new treatment options for patients suffering from a variety of chronic and acute conditions.
How similar studies have performed: Other studies have shown promising results with stem cell therapies for various conditions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and older * Ability to provide informed consent * Availability for follow up visits Exclusion Criteria: * Active or recent malignancy (within last 2 years) * Pregnancy or breast-feeding * Inability to provide informed consent
Where this trial is running
Culver City, California
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites — Culver City, California, United States (RECRUITING)
Study contacts
- Principal investigator: Ernst R Von Schwarz, MD, PhD — HeartStem Institute, Southern California Hospital at Culver City
- Study coordinator: Paul C Bogaardt, PhD(c), MSc, MBA
- Email: paul@thomasadvancedmedical.com
- Phone: 866 864 7789
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders